Table 2 Disease modifying antirheumatic drugs used by the patients at entry.

Treatment		n (%)
Single therapy		15 (62)
Methotrexate		7 (29)
Leflunomide		6 (25)
Azathioprine		1 (4)
Podophyllotoxine		1 (4)
Combination therapy		9 (38)
Methotrexate + leflunomide		1 (4)
Methotrexate + podophyllotoxine		1 (4)
Methotrexate + hydroxychloroquine + podophyllotoxine		2 (8)
Methotrexate + hydroxychloroquine + sulfasalazine +ciclosporine A		1 (4)
Azathioprine + gold sodium thiomalate		1 (4)
Azathioprine + sulfasalazine		1 (4)
Podophyllotoxine + hydroxychloroquine		1 (4)
Hydroxychloroquine + auranofin		1 (4)